Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

AJ Matas, JM Smith, MA Skeans, KE Lamb, SK Gustafson, CJ Samana, DE Stewart, JJ Snyder, AK Israni, BL Kasiske, None, OPTN/SRTR 2011 Annual Data Report: Kidney American Journal of Transplantation. ,vol. 13, pp. 11- 46 ,(2013) , 10.1111/AJT.12019

Xavier Forns, Michael Charlton, Jill Denning, John G McHutchison, William T Symonds, Diana Brainard, Theo Brandt‐Sarif, Paul Chang, Valerie Kivett, Lluís Castells, Martín Prieto, Robert J Fontana, Thomas F Baumert, Audrey Coilly, Maria Carlota Londoño, François Habersetzer, None, Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation Hepatology. ,vol. 61, pp. 1485- 1494 ,(2015) , 10.1002/HEP.27681

J. F. TROTTER, J. C. OSBORNE, M. HELLER, U. CHRISTIANS, Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. Alimentary Pharmacology & Therapeutics. ,vol. 22, pp. 37- 44 ,(2005) , 10.1111/J.1365-2036.2005.02502.X

Michael Charlton, Kris Ruppert, Steven H. Belle, Nathan Bass, Daniel Schafer, Russell H. Wiesner, Katherine Detre, Yuling Wei, James Everhart, Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transplantation. ,vol. 10, pp. 1120- 1130 ,(2004) , 10.1002/LT.20211

Ren[eacute] Adam, Paul McMaster, John G. O[apos ]Grady, Denis Castaing, Jurgen L. Klempnauer, Neville Jamieson, Peter Neuhaus, Jan Lerut, Mauro Salizzoni, Stephen Pollard, Ferdinand Muhlbacher, Xavier Rogiers, Juan Carlos Garcia Valdecasas, Joaquin Berenguer, Daniel Jaeck, Enrique Moreno Gonzalez, Evolution of liver transplantation in Europe: Report of the European liver transplant registry Liver Transplantation. ,vol. 9, pp. 1231- 1243 ,(2003) , 10.1016/J.LTS.2003.09.018

Cyrielle Delabaudière, Laurence Lavayssière, Gaëlle Dörr, Fabrice Muscari, Marie Danjoux, Federico Sallusto, Jean Marie Peron, Christophe Bureau, Lionel Rostaing, Jacques Izopet, Nassim Kamar, Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney–liver transplantation Transplant International. ,vol. 28, pp. 255- 258 ,(2015) , 10.1111/TRI.12428

Bart J. Veldt, E. Jenny Heathcote, Heiner Wedemeyer, Juerg Reichen, W. Peter Hofmann, Stefan Zeuzem, Michael P. Manns, Bettina E. Hansen, Solko W. Schalm, Harry L.A. Janssen, Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis Annals of Internal Medicine. ,vol. 147, pp. 677- 684 ,(2007) , 10.7326/0003-4819-147-10-200711200-00003

Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, Christophe Hézode, Fabien Zoulim, Philippe Mathurin, Albert Tran, Dominique G Larrey, Vlad Ratziu, Laurent Alric, Robert H Hyland, Deyuan Jiang, Brian Doehle, Phillip S Pang, William T Symonds, G Mani Subramanian, John G McHutchison, Patrick Marcellin, François Habersetzer, Dominique Guyader, Jean-Didier Grangé, Véronique Loustaud-Ratti, Lawrence Serfaty, Sophie Metivier, Vincent Leroy, Armand Abergel, Stanislas Pol, Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS) Lancet Infectious Diseases. ,vol. 15, pp. 397- 404 ,(2015) , 10.1016/S1473-3099(15)70050-2

Brian Kim, Anshu Trivedi, Swan N Thung, Priya Grewal, None, Case Report of Successful Treatment of Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin after Liver Transplantation Seminars in Liver Disease. ,vol. 34, pp. 108- 112 ,(2014) , 10.1055/S-0034-1371084

Scott A. Fink, Ira M. Jacobson, Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis Nature Reviews Gastroenterology & Hepatology. ,vol. 8, pp. 285- 295 ,(2011) , 10.1038/NRGASTRO.2011.57